105 results
-
List item
Orphan designation: dexamethasone for: Treatment of multiple myeloma
Date of designation: 09/06/2010, Withdrawn, Last updated: 12/02/2018kezelése Italian Desametasone (compressa da 40 mg) Trattamento del … -
List item
PRAC recommendations on safety signals (updated)
Last updated: 08/05/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/05/2023 -
List item
Article 5(3) opinions
Last updated: 24/02/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 04/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 31/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Download medicine data
Last updated: 02/12/2021previouslyAbasria) EMEA/H/C/002835 human en http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002835/WC500175381.pdf https://www.ema.europa.eu/en/documents/product-information/abasaglar-previously-abasria-epar-product-information_en.pdf Abecma EMEA/H/C/004662 human en https://www.ema.europa.eu/en/documents/product-information/abecma-epar-product-information_en.pdf Abevmy EMEA/H/C/005327 human en https://www.ema.europa.eu/en/documents/product-information/abevmy-epar-product-information_en.pdf Abilify EMEA/H/C/000471 human en http …
-
List item
Committee for Medicinal Products for Human Use (CHMP): 14-17 September 2020
Virtual meeting, from 14/09/2020 to 17/09/2020, Last updated: 10/03/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-8 July 2016
European Medicines Agency, London, UK, from 04/07/2016 to 08/07/2016, Last updated: 04/07/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 February 2015
European Medicines Agency, London, UK, from 09/02/2015 to 12/02/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2014
European Medicines Agency, London, UK, from 07/04/2014 to 10/04/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 1-3 October 2012
European Medicines Agency, London, UK, from 01/10/2012 to 03/10/2012, Last updated: 02/06/2012 -
List item
Paediatric Committee (PDCO): 17-19 June 2015
European Medicines Agency, London, UK, from 17/06/2015 to 19/06/2015, Last updated: 20/07/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2018
European Medicines Agency, London, UK, from 05/02/2018 to 08/02/2018, Last updated: 13/03/2014 -
List item
News: European Medicines Agency increases transparency of ongoing applications for human medicines
PRAC, Last updated: 07/11/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2016
European Medicines Agency, London, UK, from 08/02/2016 to 11/02/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2013
European Medicines Agency, London, UK, from 08/07/2013 to 11/07/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 March 2015
European Medicines Agency, London, UK, from 09/03/2015 to 12/03/2015, Last updated: 13/03/2014 -
List item
Annual reports and work programmes (updated)
Last updated: 15/05/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 February 2017
European Medicines Agency, London, UK, from 06/02/2017 to 09/02/2017, Last updated: 13/03/2014 -
List item
Management Board meeting: 17-18 March 2010
European Medicines Agency, London, UK, from 17/03/2010 to 18/03/2010, Last updated: 01/09/2011 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 November 2014
European Medicines Agency, London, UK, from 03/11/2014 to 06/11/2014, Last updated: 13/08/2013